Topical Collection on Chronic Myeloid Leukemias

ISSN: 1558-8211 (Print) 1558-822X (Online)

In this topical collection (37 articles)

Page of 2 next disabled

  1. No Access

    Chronic Myeloid Leukemias (V Oehler, Section Editor)

    Therapy Resistance and Disease Progression in CML: Mechanistic Links and Therapeutic Strategies

    John Joson Ng, S. Tiong Ong Pages 181-197

  2. No Access

    Chronic Myeloid Leukemias (V Oehler, Section Editor)

    CML Resistant to 2nd-Generation TKIs: Mechanisms, Next Steps, and New Directions

    Emilia Scalzulli, Ida Carmosino… Pages 198-205

  3. No Access

    ReviewPaper

    An Update on the Management of Advanced Phase Chronic Myeloid Leukemia

    Nicholas J. Short, Jayastu Senapati… Pages 234-242

  4. No Access

    Chronic Myeloid Leukemias (J Pinilla-Ibarz, Section Editor)

    Beyond Anthracyclines: Preemptive Management of Cardiovascular Toxicity in the Era of Targeted Agents for Hematologic Malignancies

    Tarsheen K. Sethi, Basak Basdag, Nirmanmoh Bhatia… Pages 257-267

  5. Chronic Myeloid Leukemias (M Mauro, Section Editor)

    Is There a Role for Dose Modification of TKI Therapy in CML?

    M. Copland Pages 337-345
    Download PDF (290KB) View Article

  6. Chronic Myeloid Leukemias (MJ Mauro and G Saglio, Section Editors)

    Treatment-Free Remission: the New Goal in CML Therapy

    Ehab Atallah, Kendra Sweet Pages 433-439
    Download PDF (793KB) View Article

  7. No Access

    Chronic Myeloid Leukemias (MJ Mauro and G Saglio, Section Editors)

    Challenges in Chronic Myeloid Leukemia Management in South America

    Katia B. Pagnano, Ana Ines Varela… Pages 440-447

  8. No Access

    Chronic Myeloid Leukemias (MJ Mauro and G Saglio, Section Editors)

    The Evolving Landscape of Frontline Therapy in Chronic Phase Chronic Myeloid Leukemia (CML)

    Heather R. Wolfe, Lindsay A. M. Rein Pages 448-454

  9. No Access

    Chronic Myeloid Leukemias (G Saglio, Section Editor)

    What Does Chronic Myeloid Leukaemia Tell Us About Other Leukaemias?

    Robert Peter Gale, Jane Apperley Pages 477-479

  10. No Access

    Chronic Myeloid Leukemias (G Saglio, Section Editor)

    Early Management of CML

    Naranie Shanmuganathan, Timothy P. Hughes Pages 480-491

  11. No Access

    Chronic Myeloid Leukemias (MJ Mauro and G Saglio, Section Editors)

    Health-Related Quality of Life of Patients with Chronic Myeloid Leukemia as Measured by Patient-Reported Outcomes: Current State and Future Directions

    Kelly L. Schoenbeck, Kathryn E. Flynn Pages 491-499

  12. Chronic Myeloid Leukemias (G Saglio, Section Editor)

    Towards a Personalized Treatment of Patients with Chronic Myeloid Leukemia

    Florence Rabian, Etienne Lengline, Delphine Rea Pages 492-500
    Download PDF (426KB) View Article

  13. No Access

    Chronic Myeloid Leukemias (J Pinilla-Ibarz, Section Editor)

    Minimal Residual Disease Eradication in CML: Does It Really Matter?

    Srinivas K. Tantravahi, Raga S. Guthula… Pages 495-505

  14. No Access

    Chronic Myeloid Leukemias (MJ Mauro and G Saglio, Section Editors)

    Future Directions in Chronic Phase CML Treatment

    Nathalie Javidi-Sharifi, Gabriela Hobbs Pages 500-508

  15. No Access

    Chronic Myeloid Leukemias (G Saglio, Section Editor)

    The Hidden Pathogenesis of CML: Is BCR-ABL1 the First Event?

    Naranie Shanmuganathan, Susan Branford Pages 501-506

  16. Chronic Myeloid Leukemias (G Saglio, Section Editor)

    Tyrosine Kinase Inhibitor Therapy Discontinuation for Patients with Chronic Myeloid Leukaemia in Clinical Practice

    Richard E. Clark Pages 507-514
    Download PDF (788KB) View Article

  17. No Access

    Chronic Myeloid Leukemias (MJ Mauro and G Saglio, Section Editors)

    A Multi-disciplinary Approach to Managing Chronic Myelogenous Leukemia Patients on Oral Anticancer Therapy at a Large Academic Medical Center

    Angela Canadeo, Mary Fournogerakis, Felicia Zook Pages 509-516
Page of 2 next disabled